Rchr
J-GLOBAL ID:201801009290089951   Update date: May. 09, 2024

Ho Namkoong

Namkoong Ho | Ho Namkoong
Affiliation and department:
Job title: Assistant Professor
Other affiliations (2):
  • National Institute of Allergy and Infectious Diseases  Laboratory of Clinical Immunology and Microbiology   Special Volunteer
  • Japan Science and Technology Agency
Homepage URL  (1): https://pulmonaryinfection.com/
Research field  (2): Internal medicine - General ,  Biogeoscience
Research keywords  (6): NTM Lung Disease ,  COVID-19 ,  Host susceptibility gene ,  Bronchiectasis ,  Drug Discovery for Infectious Diseases ,  Physician-led clinical trial
Research theme for competitive and other funds  (13):
  • 2024 - 2026 肺非結核性抗酸菌症患者の宿主疾患感受遺伝子の機能解析による新規治療基盤の創出
  • 2023 - 2026 Functional analysis of host disease susceptibility genes in patients with pulmonary non-tuberculous mycobacterial diseases to create a novel therapeutic strategy.
  • 2022 - 2025 Elucidation of pathogenesis of pulmonary diseases due to nontuberculous mycobacteria using the human lungs
  • 2021 - 2025 パンデミックに対してレジリエントな研究 体制構築のための基盤研究
  • 2021 - 2024 ムチン異常集積に着目した肺非結核性抗酸菌症の病態解明
Show all
Papers (244):
  • Yoshifumi Uwamino, Wataru Aoki, Rika Inose, Yuka Kamoshita, Kei Mikita, Ho Namkoong, Tomoyasu Nishimura, Hiromichi Matsushita, Naoki Hasegawa. Minimum inhibitory concentrations of azithromycin in clinical isolates of Mycobacterium avium complex in Japan. Microbiology spectrum. 2024. e0021824
  • Hirofumi Kamata, Kazufumi Takamatsu, Koichi Fukunaga, Shotaro Chubachi, Kensuke Nakagawara, Ho Namkoong, Hideki Terai, Katsushi Tanaka, Susumu Sato, Eri Hagiwara, et al. Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society. Respiratory investigation. 2024. 62. 4. 572-579
  • Shiro Otake, Yusuke Shiraishi, Shotaro Chubachi, Naoya Tanabe, Tomoki Maetani, Takanori Asakura, Ho Namkoong, Takashi Shimada, Shuhei Azekawa, Kensuke Nakagawara, et al. Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan. BMJ open respiratory research. 2024. 11. 1
  • Shuhei Azekawa, Tomoki Maetani, Shotaro Chubachi, Takanori Asakura, Naoya Tanabe, Yusuke Shiraishi, Ho Namkoong, Hiromu Tanaka, Takashi Shimada, Takahiro Fukushima, et al. CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome. Bone. 2024. 184. 117095-117095
  • Sho Uchida, Shunsuke Uno, Masahiro Kondo, Yoshifumi Uwamino, Ho Namkoong, Tomoyasu Nishimura, Kana Misawa, Shoko Kashimura, Kei Yamato, Tamami Ishizaka, et al. Factors affecting motivation for receiving a booster dose of the COVID-19 vaccine among Japanese university students and staff: a cross-sectional questionnaire survey. Scientific Reports. 2024. 14. 1. 8009-8009
more...
MISC (358):
  • 瀬山 翔史, 福田 正悟, 池谷 修, 木村 元範, 上蓑 義典, 宇野 俊介, 南宮 湖, 吉藤 歩, 内田 翔, 荒 美幸, et al. 一歩進んだ抗菌薬適正使用支援チームの活動-ASP実践のためのガイダンス第2版へ- 網羅的に取り組むAST活動 ピンチをチャンスにカエル. 感染症学雑誌. 2024. 98. 1. 61-61
  • 南宮 湖. 【非結核性抗酸菌症における新展開】最近の話題 ゲノムワイド関連解析からみえてくるリスク因子. 臨床と微生物. 2024. 51. 1. 065-068
  • 田中拓, 中鉢正太郎, 南宮湖, 朝倉崇徳, 阿瀬川周平, 李昊, 楠本竜也, 金井隆典, 福永興壱. コロナ制圧タスクフォースが明らかにした本邦のCOVID-19感染症の実態. 日本内科学会雑誌. 2024. 113. 臨増. 192-192
  • 南宮 湖. 非結核性抗酸菌感染症の基礎と臨床 日本と世界における肺非結核性抗酸菌症の疫学 持続可能な疫学調査を見据えて. 日本臨床微生物学会雑誌. 2023. 34. Suppl.1. 152-152
  • 南宮 湖. 肺非結核性抗酸菌症の新展開 疫学・抗菌化学療法・耐性検査のup to date. 日本臨床微生物学会雑誌. 2023. 34. Suppl.1. 252-252
more...
Patents (1):
Professional career (3):
  • 学士 (慶應義塾大学医学部)
  • 博士 (慶應義塾大学医学研究科)
  • 公衆衛生学修士 (Johns Hopkins Bloomberg School of Public Health)
Work history (10):
  • 2021/10 - 現在 Japan Science and Technology Agency
  • 2021/04 - 現在 慶應義塾大学医学部 感染症学教室 専任講師
  • 2019/02 - 2021/03 Japan Society for the Promotion of Science
  • 2018/04 - 2021/03 NIAID LCIM Visiting Fellow
  • 2015/10 - 2017/12 永寿総合病院 呼吸器内科・感染制御部
Show all
Awards (1):
  • 2021/11 - APSR JRS Young Scientist Award
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page